OMOP Concept 1301954
dabrafenib 10 MG Tablet for Oral Suspension [Tafinlar]
StandardDrugRxNorm2632556Branded Drug
Maps from
2
Descendants
0
Valid from
1 May 2023
Valid to
31 Dec 2099
OMOP concepts
Concept Lookup Tool
Search 11M+ concepts across SNOMED, RxNorm, ICD-10 & LOINC.
Source codes that map to this concept
2 source codes normalize to dabrafenib 10 MG Tablet for Oral Suspension [Tafinlar] via the OMOP "Maps to" relationship.
| Vocabulary | Code | Name | Type |
|---|---|---|---|
| NDC | 000781154 | dabrafenib 10mg/1 ORAL TABLET, FOR SUSPENSION | Non-standard |
| NDC | 00078115421 | dabrafenib 10 MG Tablet for Oral Suspension [Tafinlar] | Non-standard |
Synonyms
Alternative names recorded for dabrafenib 10 MG Tablet for Oral Suspension [Tafinlar] across source vocabularies.
- Tafinlar 10 MG Tablet for Oral Suspension
Where it sits in the hierarchy
Ordered by distance - 1 is a direct parent or child.
Broader concepts
(22)Roll up to these when you need a wider cohort.
- 1dabrafenib 10 MG
- 1dabrafenib 10 MG [Tafinlar]
- 1dabrafenib Oral Liquid Product
- 1dabrafenib Oral Product
- 1dabrafenib Tablet for Oral Suspension
- 1dabrafenib Tablet for Oral Suspension [Tafinlar]
- 1Tafinlar Oral Liquid Product
- 1Tafinlar Oral Product
- 2dabrafenib
- 2dabrafenib; oral
- 2Oral Liquid Product
- 2Oral Product
- 2TAFINLAR - dabrafenib capsule
- 3BRAF inhibitor
- 3B-Raf serine-threonine kinase (BRAF) inhibitors
- 4PROTEIN KINASE INHIBITORS
- 4Serine-threonine kinase inhibitor
- 5ANTINEOPLASTIC AGENTS
- 5Kinase inhibitor
- 6ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
- 6Targeted therapeutic
- 7Antineoplastics by class effect
Get this concept via the API
Resolve dabrafenib 10 MG Tablet for Oral Suspension [Tafinlar] - and every code that maps to it - over HTTPS, against the current vocabulary release. No downloads, no local database.
curl "https://api.omophub.com/v1/concepts/1301954?include_relationships=true" \
-H "Authorization: Bearer $OMOPHUB_API_KEY"Get your free API key3,000 calls/month free · no credit card